Literature DB >> 1489936

Metabolism of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay.

E G Snyderwine1, D H Welti, L B Fay, H P Würzner, R J Turesky.   

Abstract

2-Amino-3-methylimidazo[4.5-f]quinoline (IQ) is a potent bacterial mutagen and rodent carcinogen which also produces hepatocellular carcinoma in monkeys. The metabolism and disposition of this procarcinogen were investigated in monkeys undergoing carcinogen bioassay and in monkeys given an acute dose of IQ. Analysis of urine, feces, and bile revealed that IQ was extensively metabolized. A number of metabolites in urine were purified by high-performance liquid chromatography and characterized by 1H NMR and mass spectroscopy. Metabolites resulted from cytochrome P450-mediated ring oxidation at the C-5 position or N-demethylation. These metabolites could be further transformed by conjugation to sulfate or beta-glucuronic acid. Glucuronidation and sulfamate formation at the exocyclic amine group were other major routes of metabolism. Enteric bacteria also contributed to IQ biotransformation by forming the 7-oxo derivatives of IQ and N-demethyl-IQ. The metastable N2-glucuronide conjugate of the carcinogenic metabolite, 2-(hydroxyamino)-3-methylimidazo[4,5-f]quinoline, was found in urine. This indicates that metabolic activation through cytochrome P450-mediated N-oxidation occurs in vivo and that glucuronidation is a means of transport of the carcinogenic metabolite to extrahepatic tissues.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489936     DOI: 10.1021/tx00030a018

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  9 in total

1.  The C8-2'-deoxyguanosine adduct of 2-amino-3-methylimidazo[1,2-d]naphthalene, a carbocyclic analogue of the potent mutagen 2-amino-3-methylimidazo[4,5-f]quinoline, is a block to replication in vitro.

Authors:  Plamen P Christov; Goutam Chowdhury; Craig A Garmendia; Feng Wang; James S Stover; C Eric Elmquist; Albena Kozekova; Karen C Angel; Robert J Turesky; Michael P Stone; F Peter Guengerich; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

2.  UDP-glucuronosyltransferase-mediated metabolic activation of the tobacco carcinogen 2-amino-9H-pyrido[2,3-b]indole.

Authors:  Yijin Tang; David M LeMaster; Gwendoline Nauwelaërs; Dan Gu; Sophie Langouët; Robert J Turesky
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

Review 3.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

4.  Characterization of new metabolites from in vivo biotransformation of 2-amino-3-methylimidazo[4,5-f]quinoline in mouse by mass spectrometry.

Authors:  Fong-Fu Hsu; Vijaya M Lakshmi; Terry V Zenser
Journal:  J Mass Spectrom       Date:  2009-09       Impact factor: 1.982

5.  N-Demethylation is a major route of 2-amino-3-methylimidazo[4,5-f]quinoline metabolism in mouse.

Authors:  Vijaya M Lakshmi; Fong Fu Hsu; Terry V Zenser
Journal:  Drug Metab Dispos       Date:  2008-03-20       Impact factor: 3.922

6.  Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.

Authors:  Vijaya M Lakshmi; Fong-Fu Hsu; Terry V Zenser
Journal:  Drug Metab Dispos       Date:  2009-05-18       Impact factor: 3.922

Review 7.  Metabolism and biomarkers of heterocyclic aromatic amines in humans.

Authors:  Medjda Bellamri; Scott J Walmsley; Robert J Turesky
Journal:  Genes Environ       Date:  2021-07-16

8.  Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring.

Authors:  R J Turesky; G A Gross; W G Stillwell; P L Skipper; S R Tannenbaum
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

9.  Formation of 2-amino-3-methylimidazo[4,5-f]quinoline- and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-sulfamates by cDNA-expressed mammalian phenol sulfotransferases.

Authors:  S Ozawa; K Nagata; Y Yamazoe; R Kato
Journal:  Jpn J Cancer Res       Date:  1995-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.